These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
194 related items for PubMed ID: 7646591
21. Effect of intravenous 1-alpha-hydroxyvitamin D3 on secondary hyperparathyroidism in chronic uremic patients on maintenance hemodialysis. Brandi L, Daugaard H, Tvedegaard E, Storm T, Olgaard K. Nephron; 1989; 53(3):194-200. PubMed ID: 2797340 [Abstract] [Full Text] [Related]
22. Increased catabolism of 25-hydroxyvitamin D in patients with partial gastrectomy and elevated 1,25-dihydroxyvitamin D levels. Implications for metabolic bone disease. Davies M, Heys SE, Selby PL, Berry JL, Mawer EB. J Clin Endocrinol Metab; 1997 Jan; 82(1):209-12. PubMed ID: 8989260 [Abstract] [Full Text] [Related]
23. [Course of blood levels of calcium, inorganic phosphate, alkaline phosphatase, parathyroid hormone and calcidiol (25-OH-D3) in one and two year old thoroughbred horses]. Enbergs H, Karp HP, Schönherr U. Dtsch Tierarztl Wochenschr; 1996 Dec; 103(12):491-3. PubMed ID: 9333537 [Abstract] [Full Text] [Related]
24. The 'oral 1,25-dihydroxyvitamin D3 pulse therapy' in hemodialysis patients with severe secondary hyperparathyroidism. Tsukamoto Y, Nomura M, Takahashi Y, Takagi Y, Yoshida A, Nagaoka T, Togashi K, Kikawada R, Marumo F. Nephron; 1991 Dec; 57(1):23-8. PubMed ID: 2046811 [Abstract] [Full Text] [Related]
25. Anticonvulsant drug-induced osteomalacia: alterations in mineral metabolism and response to vitamin D3 administration. Hahn TJ, Halstead LR. Calcif Tissue Int; 1979 Mar 13; 27(1):13-8. PubMed ID: 223750 [Abstract] [Full Text] [Related]
26. Use of 1,25(OH)2-vitamin D3 to separate 'types' on renal osteodystrophy. Coburn JW, Brickman AS, Sherrard DJ, Singer FR, Wong EG, Baylink DJ, Norman AW. Proc Eur Dial Transplant Assoc; 1977 Mar 13; 14():442-50. PubMed ID: 600961 [Abstract] [Full Text] [Related]
27. A case of normocalcemic primary hyperparathyroidism with osteomalacia. Shimada I, Inaba M, Nakano H, Miki T, Nishizawa Y, Morii H. Endocrinol Jpn; 1986 Oct 13; 33(5):575-82. PubMed ID: 3830067 [Abstract] [Full Text] [Related]
28. Determinants for serum 1,25-dihydroxycholecalciferol in primary hyperparathyroidism. Mosekilde L, Charles P, Lindegreen P. Bone Miner; 1989 Mar 13; 5(3):279-90. PubMed ID: 2720198 [Abstract] [Full Text] [Related]
29. [Relative depletion in native vitamin D: a potential risk factor in Algerian hemodialysis patients with radiological evidence of hyperparathyroidism and osteomalacia independent of calcitriolemia]. Atik A, Ghazali A, Achard JM, Rida Z, Oprisiu R, Brazier M, Leflon P, Gueris J, Morinière P, Sari Z, Fournier A. Nephrologie; 1997 Mar 13; 18(2):47-52. PubMed ID: 9182233 [Abstract] [Full Text] [Related]
30. Long-term effects of intravenous 1 alpha (OH)D3 combined with CaCO3 and low-calcium dialysis on secondary hyperparathyroidism and biochemical bone markers in patients on chronic hemodialysis. Brandi L, Daugaard H, Nielsen PK, Jensen LT, Egsmose C, Olgaard K. Nephron; 1996 Mar 13; 74(1):89-103. PubMed ID: 8883025 [Abstract] [Full Text] [Related]
31. Oncogenic osteomalacia cured by removal of an organized hematoma. Colt E, Gopan T, Chong HS. Endocr Pract; 2005 Mar 13; 11(3):190-3. PubMed ID: 16239206 [Abstract] [Full Text] [Related]
32. Vitamin D Metabolites and Their Association with Calcium, Phosphorus, and PTH Concentrations, Severity of Illness, and Mortality in Hospitalized Equine Neonates. Kamr AM, Dembek KA, Reed SM, Slovis NM, Zaghawa AA, Rosol TJ, Toribio RE. PLoS One; 2015 Mar 13; 10(6):e0127684. PubMed ID: 26046642 [Abstract] [Full Text] [Related]
33. Normal plasma calcium, phosphate, and parathyroid hormone levels during 1,25(OH)2D3 infusions in rats. Fox J, Kollenkirchen U. Am J Physiol; 1992 Jan 13; 262(1 Pt 1):E126-9. PubMed ID: 1733243 [Abstract] [Full Text] [Related]
34. 1 alpha,25-dihydroxyvitamin D3 corrects osteomalacia in hypoparathyroidism and pseudohypoparathyroidism. Epstein S, Meunier PJ, Lambert PW, Stern PH, Bell NH. Acta Endocrinol (Copenh); 1983 Jun 13; 103(2):241-7. PubMed ID: 6687971 [Abstract] [Full Text] [Related]
35. Effects of oral phosphorus supplementation on mineral metabolism of renal transplant recipients. Caravaca F, Fernández MA, Ruiz-Calero R, Cubero J, Aparicio A, Jimenez F, García MC. Nephrol Dial Transplant; 1998 Oct 13; 13(10):2605-11. PubMed ID: 9794568 [Abstract] [Full Text] [Related]
36. [Diagnosis of anticonvulsant osteomalacia in adults (author's transl)]. Krause KH, Prager P, Schmidt-Gayk H, Ritz E. Dtsch Med Wochenschr; 1977 Dec 23; 102(51):1872-7. PubMed ID: 598289 [Abstract] [Full Text] [Related]
37. Effect of 24,25-dihydroxyvitamin D3 on 1,25-dihydroxyvitamin D3 metabolism in calcium-deficient rats. Matsumoto T, Ikeda K, Yamato H, Morita K, Ezawa I, Fukushima M, Nishii Y, Ogata E. Biochem J; 1988 Mar 15; 250(3):671-7. PubMed ID: 2839142 [Abstract] [Full Text] [Related]
38. Tumor-induced hypophosphatemic osteomalacia associated with tertiary hyperparathyroidism: a case report. Tartaglia F, Minisola S, Sgueglia M, Blasi S, Brunelli D, Degli Effetti E, Maturo A, Cola A, Custureri F, Campana FP. G Chir; 2006 Mar 15; 27(1-2):9-13. PubMed ID: 16608626 [Abstract] [Full Text] [Related]
39. Serum calcium and 25-OH-D3 in mothers of newborns with craniotabes. Kokkonen J, Koivisto M, Lautala P, Kirkinen P. J Perinat Med; 1983 Mar 15; 11(2):127-31. PubMed ID: 6854510 [Abstract] [Full Text] [Related]
40. Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Oelzner P, Müller A, Deschner F, Hüller M, Abendroth K, Hein G, Stein G. Calcif Tissue Int; 1998 Mar 15; 62(3):193-8. PubMed ID: 9501950 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]